The study observed a difference in the relationship between the median serum concentrations of FGF19 and FGF22 in patients with type 1 and type 2 diabetes, as well as in the control group (p < 0.001; p < 0.001). The gene discussed is FGF19; the disease is type 2 diabetes mellitus.